Research Topics


Quan Yong Luo


Affiliation: Fudan University
Country: China


  1. Zhang X, Song H, Qiu Z, Shen C, Chen X, Sun Z, et al. Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with 131I. Endocrine. 2018;62:149-158 pubmed publisher
    ..Tumor doubling time and tumor diameter were the main factors influencing both progression-free survival and overall survival. ..
  2. Qiu Z, Shen C, Song H, Wei W, Luo Q. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study. Nucl Med Biol. 2015;42:499-504 pubmed publisher
    ..These findings in our present study could represent new clues for the diagnostic and therapeutic strategy in PTC patients with non-(131)I-avid metastatic disease. ..
  3. Shen C, Wei W, Qiu Z, Song H, Luo Q. Value of post-therapeutic ¹³¹I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma. Endocrine. 2016;51:283-90 pubmed publisher
    ..US had limitations in PTP-TN patients, while post-therapy (131)I-SPECT/CT demonstrated an advantage in the detection of functioning metastasis despite low sTg levels in patients with metastatic DTC. ..
  4. Song H, Qiu Z, Shen C, Wei W, Luo Q. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. Eur J Endocrinol. 2015;173:399-408 pubmed publisher
    ..Younger patients (<40 years old) with only pulmonary metastases and small ('fine miliaric' or micronodular) metastases appear to have relative favorite outcomes. Patients who do not respond to (131)I treatment have a worse prognosis. ..
  5. Wei W, Shen C, Song H, Qiu Z, Luo Q. Comparison of SPET/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: A meta-analysis. Hell J Nucl Med. 2015;18:127-35 pubmed publisher
    ..We firmly believe that this technique will be the main diagnostic means, to detect PHPT lesions and support minimally invasive parathyroidectomy. ..
  6. Wei W, Jiang D, Ehlerding E, Luo Q, Cai W. Noninvasive PET Imaging of T cells. Trends Cancer. 2018;4:359-373 pubmed publisher
  7. Shen C, Wei W, Qiu Z, Song H, Luo Q. Afamin promotes glucose metabolism in papillary thyroid carcinoma. Mol Cell Endocrinol. 2016;434:108-15 pubmed publisher
    ..In conclusion, afamin could promote glycometabolism by up-regulating the glucose metabolism key enzymes in papillary thyroid carcinoma. These findings reveal new clues of the molecular function of AFM. ..
  8. request reprint
    Shen C, Wei W, Qiu Z, Song H, Zhang X, Sun Z, et al. Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo. J Mol Endocrinol. 2017;58:15-23 pubmed
  9. Shen C, Qiu Z, Song H, Wei W, Luo Q. miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway. J Exp Clin Cancer Res. 2016;35:101 pubmed publisher
    ..These findings in the present study may provide new strategies for the diagnosis and treatment in radioiodine-refractory differentiated thyroid carcinoma. ..

More Information


  1. Qiu Z, Wei W, Shen C, Song H, Zhang X, Sun Z, et al. Diagnostic Performance of 18F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative 131I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb Level. Sci Rep. 2017;7:2849 pubmed publisher
  2. Wei W, Ehlerding E, Lan X, Luo Q, Cai W. PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging. 2018;45:132-150 pubmed publisher
    ..In this review, we focus on the latest developments in radiolabeled molecular imaging probes for melanoma in preclinical and clinical settings, and discuss the challenges and opportunities for future development. ..
  3. Qiu Z, Song H, Xu Y, Luo Q. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab. 2011;96:3078-86 pubmed publisher
    ..Our objective was to investigate the clinical efficacy of (131)I therapy for bone metastases from differentiated thyroid cancer (DTC) and prognostic factors as well as to assess patient survival and variables influencing survival...
  4. Shen C, Zhang X, Qiu Z, Sun Z, Wei W, Song H, et al. Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword?. Endocrine. 2017;58:176-183 pubmed publisher
    ..The association between thyroid autoimmunity and thyroid cancer can be patient and antibody specific. A systemic immunosupression status may exist in PTC patients with distant metastasis. ..
  5. Wei W, Zhang G, Luo Q. Postsurgical Management of Differentiated Thyroid Cancer in China. Trends Endocrinol Metab. 2018;29:71-73 pubmed publisher
    ..Here, we briefly review the current status and also extend an outlook for future development. ..